Trials / Conditions / Myeloblastic Leukemia

Myeloblastic Leukemia

4 registered clinical trials studyying Myeloblastic Leukemia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Child NCT06756152	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Phase 2 / Phase 3
Active Not Recruiting	Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibito NCT05515029	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Phase 3
Completed	Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute L NCT01615809	Fundació Sant Joan de Déu	Phase 2
Unknown	Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-misma NCT00799799	University of Bologna	Phase 1